M. Bast

发表

Prognostic significance of clinical and pathologic features in diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 1993, Cancer.

Stromal gene signatures in large-B-cell lymphomas.

L. Staudt, W. C. Chan, A. Rosenwald, 2008, The New England journal of medicine.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Steven J. M. Jones, Christian Steidl, Javeed Iqbal, 2010, The New England journal of medicine.

Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis

D. Weisenburger, J. Armitage, M. Bast, 1991, Cancer.

Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

D. Weisenburger, J. Armitage, M. Bast, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma

J. Armitage, P. Bierman, R. Bociek, 2013, Revista brasileira de hematologia e hemoterapia.

Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma.

P. Bierman, J. Vose, M. Bast, 2015, Clinical lymphoma, myeloma & leukemia.

Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases

B. Nathwani, D. Weisenburger, J. Armitage, 2016, British journal of haematology.

Peripheral T‐cell lymphoma

B. Nathwani, D. Weisenburger, J. Armitage, 1989, Cancer.

CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience

T. Greiner, D. Weisenburger, J. Armitage, 2002, Leukemia & lymphoma.

Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project

B. Nathwani, D. Weisenburger, J. Armitage, 2015, British journal of haematology.

Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy

R. Tibshirani, I. Lossos, Y. Natkunam, 2008, Laboratory Investigation.

Lymphomatous polyposis. A neoplasm of either follicular mantle or germinal center cell origin.

D. Weisenburger, M. Bast, J. Delabie, 1996, The American journal of surgical pathology.

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.

Robert Tibshirani, Yasodha Natkunam, Arnon Nagler, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular diagnosis of Burkitt's lymphoma.

Richard Simon, Kai Fu, Jan Delabie, 2006, The New England journal of medicine.

Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.

J. Armitage, J. Vose, M. Bast, 1999, Leukemia & lymphoma.

Immunoblastic lymphoma with abundant clear cytoplasm. A comparative study of B- and T-cell types.

D. Weisenburger, J. Armitage, H. Nakamine, 1991, American journal of clinical pathology.

Mantle zone lymphoma a clinicopathologic study of 22 cases

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer.

Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study.

D. Weisenburger, J. Armitage, M. Bast, 1987, Human pathology.

Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults

D. Weisenburger, J. Armitage, J. Vose, 2017 .

Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.

W. Chan, D. Weisenburger, J. Armitage, 1994, Seminars in hematology.

Cytogenetic abnormalities in B-immunoblastic lymphoma.

D. Weisenburger, J. Armitage, M. Bast, 1994, Leukemia & lymphoma.

#461 Cytogenetic abnormalities in tumors from children with non-Hodgkinʼs lymphoma (NHL) or Hodgkinʼs disease (HD): Nebraska Lymphoma Study Group experience

D. Weisenburger, J. Armitage, M. Bast, 1999 .

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

B. Nathwani, D. Weisenburger, J. Armitage, 2016, Haematologica.

Peripheral T‐cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients

D. Weisenburger, J. Armitage, J. Vose, 1993, Cancer.

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Ash A. Alizadeh, Michael R. Green, R. Davis, 2017, bioRxiv.

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation

W. Chan, T. Greiner, D. Weisenburger, 2012, Hematological oncology.

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

Ash A. Alizadeh, Michael R. Green, T. Greiner, 2016, Blood.

Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics.

D. Weisenburger, J. Armitage, M. Bast, 1995, Cancer genetics and cytogenetics.

Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18).

D. Weisenburger, J. Armitage, M. Bast, 1995, Leukemia & lymphoma.

Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project

B. Nathwani, D. Weisenburger, J. Armitage, 2016, British journal of haematology.

Characteristics and outcomes of diffuse large B‐cell lymphoma presenting in leukaemic phase

D. Weisenburger, J. Armitage, M. Bast, 2012, British journal of haematology.

A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome.

M. Bast, S. Walmsley, I. Salit, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable

Scott E. Smith, J. Vose, M. Bast, 2016, British journal of haematology.

Chapter 4 Molecular Diagnosis of Burkitt lymphoma

Armitage, L. Staudt, A. Rosenwald, 2019 .

Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project

B. Nathwani, D. Weisenburger, J. Armitage, 2015, Annals of Hematology.

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience

T. Greiner, J. Armitage, Lynette M. Smith, 2016, Leukemia & lymphoma.

Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.

J. Armitage, M. Bast, T. Habermann, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.

I. Lossos, Y. Natkunam, M. Bast, 2005, Blood.

Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 1995, Blood.

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.

Charles Enke, W. Chan, T. Greiner, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.

W. Chan, T. Greiner, D. Weisenburger, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma

D. Weisenburger, J. Armitage, Lynette M. Smith, 2004, American journal of hematology/oncology.

A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era

R. Tibshirani, I. Lossos, R. Advani, 2014, British journal of haematology.

Non‐Hodgkin lymphoma of the prostate

P. Bierman, J. Vose, M. Bast, 2011, American journal of hematology.

Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer research.

Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer.

Late relapse in patients with diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 2010, British journal of haematology.

Histologic grade does not predict prognosis in optimally treated, advanced‐stage nodular sclerosing Hodgkin's disease

D. Weisenburger, J. Armitage, J. Vose, 1992, Cancer.

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.

J. Vose, M. Bast, R. Fisher, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B‐cell lymphoma

W. C. Chan, J. Armitage, P. Bierman, 2012, British journal of haematology.

Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 1996, Blood.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

Kai Fu, Patricia Aoun, Timothy C Greiner, 2014, British journal of haematology.

Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

D. Weisenburger, J. Armitage, P. Bierman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

A. Rosenwald, D. Weisenburger, J. Armitage, 2019, Haematologica.

Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification

B. Nathwani, D. Weisenburger, J. Armitage, 2015, Leukemia & lymphoma.

CD43 expression is associated with inferior survival in the non‐germinal centre B‐cell subgroup of diffuse large B‐cell lymphoma

W. C. Chan, T. Greiner, J. Armitage, 2013, British journal of haematology.

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

L. Staudt, A. Rosenwald, J. Powell, 2007 .

LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras.

R. Tibshirani, I. Lossos, Y. Natkunam, 2007 .

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

W. Chan, T. Greiner, D. Weisenburger, 2015, Leukemia & lymphoma.

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

D. Weisenburger, J. Vose, M. Bast, 2009, Leukemia & lymphoma.

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J. Vose, M. Bast, F. Hernandez-Ilizaliturri, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

D. Weisenburger, J. Armitage, P. Bierman, 2009, British journal of haematology.

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission

J. Armitage, J. Vose, M. Bast, 2014, Cancer.

Clinical or survival benefit to routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

J. Armitage, J. Vose, M. Bast, 2013 .

Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.

R. Tibshirani, I. Lossos, Y. Natkunam, 2007 .

Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?

D. Weisenburger, J. Armitage, P. Bierman, 2013, Clinical lymphoma, myeloma & leukemia.

Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells.

M. Bast, A. Rachlis, A. Klein, 1992, AIDS.

Peripheral T‐cell lymphoma

B. Nathwani, D. Weisenburger, J. Armitage, 1989, Cancer.

Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience

T. Greiner, J. Armitage, P. Bierman, 2014 .

Late relapse in patients with diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 2010, British journal of haematology.

Non‐Hodgkin lymphoma of the prostate

D. Weisenburger, P. Bierman, J. Vose, 2011, American journal of hematology.

Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma.

P. Bierman, J. Vose, M. Bast, 2015, Clinical lymphoma, myeloma & leukemia.

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

J. Vose, M. Bast, F. Hernandez-Ilizaliturri, 2023, Blood advances.